Trial shows benefits of targeted drug against early-stage breast cancer with inherited BRCA mutation 03 Jun 2021 Women with high-risk, early-stage breast cancer who also have inherited faults in their BRCA1 or BRCA2 genes have shown a remarkable response to the targeted drug olaparib in a major clinical trial. Find out more Show/Hide
New type of treatment could reawaken immune response against prostate cancer 07 May 2021 Targeting a molecule on the surface of immune cells could offer an exciting new way to treat prostate cancer by reawakening the immune response against it. Find out more Show/Hide
First Covid jab provides protection for most myeloma blood cancer patients 19 Apr 2021 A single dose of a Covid-19 vaccine triggers an immune response in around 70 per cent of patients with myeloma – suggesting that it does provide protection against the virus. Find out more Show/Hide
Existing breast cancer drug offers new targeted treatment for triple negative breast cancer 28 Jan 2021
New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers 29 Oct 2020